350 related articles for article (PubMed ID: 30566209)
21. Effects of alcohol septal ablation on left ventricular diastolic filling patterns in obstructive hypertrophic cardiomyopathy.
Chen YZ; Duan FJ; Yuan JS; Hu FH; Cui JG; Yang WX; Zhang Y; Wang H; Qiao SB
Heart Vessels; 2016 May; 31(5):744-51. PubMed ID: 25739657
[TBL] [Abstract][Full Text] [Related]
22. Time and age dependent decrease of NT-proBNP after septal myectomy in hypertrophic obstructive cardiomyopathy.
Cui H; Wu X; Wang S; Tang B; Zhu C; Chen H; Zhou X; Wu R; Yu Q; Huang X
Clin Chem Lab Med; 2017 Aug; 55(10):1614-1620. PubMed ID: 28301315
[TBL] [Abstract][Full Text] [Related]
23. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
[TBL] [Abstract][Full Text] [Related]
24. Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.
Elasfar A
Ann Saudi Med; 2012; 32(5):469-72. PubMed ID: 22871614
[TBL] [Abstract][Full Text] [Related]
25. Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.
Timmer SA; Knaapen P; Germans T; Lubberink M; Dijkmans PA; Vonk-Noordegraaf A; Ten Berg JM; Ten Cate FJ; Lammertsma AA; van Rossum AC
J Card Fail; 2011 Oct; 17(10):827-31. PubMed ID: 21962421
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
[No Abstract] [Full Text] [Related]
27. Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
Alabdaljabar MS; Cendrowski EE; Nishimura RA; Miranda WR; Geske JB; Rihal CS; Eleid MF
Circ Cardiovasc Interv; 2023 Aug; 16(8):e013068. PubMed ID: 37582173
[TBL] [Abstract][Full Text] [Related]
28. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
[TBL] [Abstract][Full Text] [Related]
29. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
[TBL] [Abstract][Full Text] [Related]
31. Determinants of elevated NT-proBNP levels in patients with hypertrophic cardiomyopathy: an echocardiographic study.
Kahveci G; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2009 Aug; 18(4):266-70. PubMed ID: 19157978
[TBL] [Abstract][Full Text] [Related]
32. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Vermaete I; Dujardin K; Stammen F
Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
[No Abstract] [Full Text] [Related]
33. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.
Liu L; Li J; Zuo L; Zhang J; Zhou M; Xu B; Hahn RT; Leon MB; Hsi DH; Ge J; Zhou X; Zhang J; Ge S; Xiong L
J Am Coll Cardiol; 2018 Oct; 72(16):1898-1909. PubMed ID: 30309466
[TBL] [Abstract][Full Text] [Related]
35. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
36. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
Hori Y; Fujimoto E; Nishikawa Y; Nakamura T
J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
[TBL] [Abstract][Full Text] [Related]
38. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
[TBL] [Abstract][Full Text] [Related]
39. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
40. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
